BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9855248)

  • 21. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
    Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
    Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
    Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global characteristics of childhood acute promyelocytic leukemia.
    Zhang L; Samad A; Pombo-de-Oliveira MS; Scelo G; Smith MT; Feusner J; Wiemels JL; Metayer C
    Blood Rev; 2015 Mar; 29(2):101-25. PubMed ID: 25445717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Pagano L; Pulsoni A; Tosti ME; Annino L; Mele A; Camera A; Martino B; Guglielmi C; Cerri R; Di Bona E; Invernizzi R; Castagnola C; Bassan R; Mele L; Todeschini G; Leone G; Mandelli F
    Br J Haematol; 1999 Sep; 106(4):1037-40. PubMed ID: 10520009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of acute promyelocytic leukemia in northwest Iran.
    Ziaei JE
    Asian Pac J Cancer Prev; 2004; 5(2):188-9. PubMed ID: 15244523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA.
    Avvisati G; Mandelli F; Petti MC; Vegna ML; Spadea A; Liso V; Specchia G; Bernasconi C; Alessandrino EP; Piatti C
    Eur J Haematol; 1990 Apr; 44(4):257-60. PubMed ID: 2188854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.
    Sanz MA; Montesinos P; Kim HT; Ruiz-Argüelles GJ; Undurraga MS; Uriarte MR; Martínez L; Jacomo RH; Gutiérrez-Aguirre H; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Vellenga E; Holowiecka A; González-Huerta AJ; Fernández P; De la Serna J; Brunet S; De Lisa E; González-Campos J; Ribera JM; Krsnik I; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Rego EM;
    Ann Hematol; 2015 Aug; 94(8):1347-56. PubMed ID: 25975975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
    Lobe I; Rigal-Huguet F; Vekhoff A; Desablens B; Bordessoule D; Mounier C; Ferrant A; Sanz M; Fey M; Chomienne C; Chevret S; Degos L; Fenaux P;
    Leukemia; 2003 Aug; 17(8):1600-4. PubMed ID: 12886249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry.
    Chen Z; Li Y; Tong Y; Gao Q; Mao X; Zhang W; Xia Z; Fu C
    Int J Hematol; 2016 Mar; 103(3):306-15. PubMed ID: 26759321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EVI1 expression in acute myeloid leukaemia.
    Langabeer SE; Rogers JR; Harrison G; Wheatley K; Walker H; Bain BJ; Burnett AK; Goldstone AH; Linch DC; Grimwade D;
    Br J Haematol; 2001 Jan; 112(1):208-11. PubMed ID: 11167805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
    Batzios C; Hayes LA; He SZ; Quach H; McQuilten ZK; Wall M; Campbell LJ
    Am J Hematol; 2009 Nov; 84(11):715-9. PubMed ID: 19806661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
    Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
    Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of PMN elastase in fibrinolytic activity in patients with acute promyelocytic leukemia].
    Soma M; Maeda Y; Kasakura S; Yabe H
    Rinsho Ketsueki; 1990 Sep; 31(9):1445-9. PubMed ID: 2246816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coffee and tea consumption and risk of leukaemia in an adult population: A reanalysis of the Italian multicentre case-control study.
    Parodi S; Merlo DF; Stagnaro E;
    Cancer Epidemiol; 2017 Apr; 47():81-87. PubMed ID: 28153669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor XIII Subunit A Immunohistochemical Expression is Associated With Inferior Outcomes in Acute Promyelocytic Leukemia.
    Raval JS; Berg AN; Djokic M; Roth CG; Rollins-Raval MA
    Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):202-205. PubMed ID: 27299191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of PG-M3 antibody in the diagnosis of acute promyelocytic leukaemia.
    Gupta SK; Sazawal S; Mahapatra M; Saxena R
    Eur J Clin Invest; 2010 Oct; 40(10):960-2. PubMed ID: 20701624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
    Riccioni R; Pasquini L; Mariani G; Saulle E; Rossini A; Diverio D; Pelosi E; Vitale A; Chierichini A; Cedrone M; Foà R; Lo Coco F; Peschle C; Testa U
    Haematologica; 2005 May; 90(5):612-24. PubMed ID: 15921376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy.
    Elliott MA; Letendre L; Tefferi A; Hogan WJ; Hook C; Kaufmann SH; Pruthi RK; Pardanani A; Begna KH; Ashrani AA; Wolanskyj AP; Al-Kali A; Litzow MR
    Eur J Haematol; 2012 Mar; 88(3):237-43. PubMed ID: 22023492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.